|
SEED Grant |
John Cashman |
Discovering Potent Molecules with Human ESCs to Treat Heart Disease |
$688,274 |
|
Early Translational IV |
John Cashman |
Improving Existing Drugs for Long QT Syndrome type 3 (LQT3) by hiPSC Disease-in-Dish Model |
$6,361,369 |
|
Patent Assistance Fund Awards |
John Cashman |
Intellectual Property for Stem Cell-Related Inventions - HBRI |
$50,000 |
|
Inception - Discovery Stage Research Projects |
John Cashman |
Human Pancreatic Cancer Stem Cells: Developing a Novel Drug for Cancer Eradication |
$303,785 |
